Financial PerformanceESTA's valuation is considered attractive given its growth potential.
Market TractionThe US launch is progressing well with average daily orders continuing to rise.
Product AdoptionThe surgeon has shifted the majority of his breast implant use to Motiva, citing the premier safety/efficacy profile, premium product appeal, natural feel, and patient demand.